Evidence map›Paper›PMID 21681934›Full record

ArticlePediatric blood & cancer2012

Constitutional tandem duplication of 9q34 that truncates EHMT1 in a child with ganglioglioma.

Hannah C Cheung, Svetlana A Yatsenko, Meena Kadapakkam, Hélène Legay, Jack Su, James R Lupski, Sharon E Plon

Abstract readCase Reports
In one paragraph

Article in Pediatric blood & cancer, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Potential Epigenetic-Based Therapeutic Targets for Glioma.Frontiers in molecular neuroscience · 2018
    Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Hannah C CheungTexas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
Svetlana A Yatsenko
Meena Kadapakkam
Hélène Legay
Jack Su
James R Lupski
Sharon E Plon
Baylor College of Medicine · USChildren's Cancer Center · USUniversité Claude Bernard Lyon 1 · FR

Funding

Genomic Approaches to Defining Inherited Basis of Childhood CancerR01CA138836 · NCI · BAYLOR COLLEGE OF MEDICINE · PI PLON, SHARON E. · 2010 to 2012
$1.7M
Intramural NIH HHSNCI NIH HHS 5R01CA138836NCI NIH HHS R01 CA138836
6 · The paper itself

Abstract

Point mutations of EHMT1 or deletions and duplications of chromosome 9q34.3 are found in patients with variable neurologic and developmental disorders. Here, we present a child with congenital cataract, developmental and speech delay who developed a metastatic ganglioglioma with progression to anaplastic astrocytoma. Molecular analysis identified a novel constitutional tandem duplication in 9q34.3 with breakpoints in intron 1 of TRAF2 and intron 16 of EHMT1 generating a fusion transcript predicted to encode a truncated form of EHMT1. The ganglioglioma showed complex chromosomal aberrations with further duplication of the dup9q34. Thus, this unique tandem 9q34.3 duplication may impact brain tumor formation.

Indexed as

Chromosome DuplicationChromosomes, Human, Pair 9Child, PreschoolFemaleGangliogliomaHistone-Lysine N-MethyltransferaseHumansTNF Receptor-Associated Factor 2EHMT1 protein, humanHistone-Lysine N-MethyltransferaseTNF Receptor-Associated Factor 2

Identifiers

PMID21681934
PMCPMC3202030
OpenAlexW2015338858

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.